Annual CFF
$8.13 M
+$7.43 M+1056.64%
December 31, 2023
Summary
- As of February 21, 2025, GDTC annual cash flow from financing activities is $8.13 million, with the most recent change of +$7.43 million (+1056.64%) on December 31, 2023.
- During the last 3 years, GDTC annual CFF has risen by +$6.76 million (+495.12%).
- GDTC annual CFF is now at all-time high.
Performance
GDTC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GDTC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1056.6% | - | - |
| 3 y3 years | +495.1% | - | - |
| 5 y5 years | +495.1% | - | - |
GDTC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1056.6% | ||||
| 5 y | 5-year | at high | +1056.6% | ||||
| alltime | all time | at high | +1056.6% |
CytoMed Therapeutics Limited Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $8.13 M(+1056.6%) | - | - |
| Dec 2022 | $702.90 K(-77.4%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $3.11 M(+127.3%) | - | - |
| Dec 2020 | $1.37 M | - | - |
FAQ
- What is CytoMed Therapeutics Limited annual cash flow from financing activities?
- What is the all time high annual CFF for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual CFF year-on-year change?
What is CytoMed Therapeutics Limited annual cash flow from financing activities?
The current annual CFF of GDTC is $8.13 M
What is the all time high annual CFF for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual cash flow from financing activities is $8.13 M
What is CytoMed Therapeutics Limited annual CFF year-on-year change?
Over the past year, GDTC annual cash flow from financing activities has changed by +$7.43 M (+1056.64%)